Search earnings tickers

VRTX

2024Q2AMC

Vertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-08-01 · Fiscal end 2024-06-30 · Features as of 2024-08-01

← Earnings history

Street

Consensus EPS-11.75

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.9%

IV front—

P/C full—

P/C front—

Features as of2024-08-01

Run-up

Close—

Ret 5d+2.7%

Ret 10d+3.6%

Ret 20d+7.5%

Ret 30d+8.2%

Print

Actual EPS

-12.83Miss

Estimated EPS-11.75

Actual revenue

2.6B

Surprise %-9.2%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction+0.6%

Implied vs actual

Implied 1.9%Actual 2.8%

Gap reaction-2.8%

Day result-2.2%

Next-day upYes

Realized / IV1.45×

Post tape

Post 5d-5.3%

Post 10d-3.5%

Post volume1.6M

Vol ×10d1.39×

Vol ×20d1.48×

Post range3.6%